Download Product Catalogue

Product Detail

EDARAKAL

EDARAKAL

Edaravone 20ML Injection

Functions as a free radical scavenger, which prevents the oxidative damage of brain cells.

Functions as a free radical scavenger, which prevents the oxidative damage of brain cells Enhances neurological outcome in ischemic stroke Delays the development of ALS, and allows maintaining motor activity.

MRP: ₹834/-
Send Enquiry

100%

Certified Products

Secure

pAYMENTS

24/7

Customer Support

100%

Certified Products

Secure

PAYMENTS

24/7

Customer Support

About The Product

Uses

Functions as a free radical scavenger, which prevents the oxidative damage of brain cells Enhances neurological outcome in ischemic stroke Delays the development of ALS, and allows maintaining motor activity.

Side Effects

  • Headache, dizziness Nausea, vomiting Itching, rash, allergies Edema, chest pain (uncommon) Some patients have abnormal liver function tests

Uses

Functions as a free radical scavenger, which prevents the oxidative damage of brain cells Enhances neurological outcome in ischemic stroke Delays the development of ALS, and allows maintaining motor activity.

Side Effects

  • Headache, dizziness Nausea, vomiting Itching, rash, allergies Edema, chest pain (uncommon) Some patients have abnormal liver function tests

Indications

  • Acute ischemic stroke- to minimize neurological disability Amyotrophic Lateral Sclerosis (ALS) - reduces the pace of the disease Neurological diseases related to oxidative stress

FAQ

Q1: What is EDARAKAL Injection?
A1: It is primarily applied in acute ischemic stroke and in patients with Amyotrophic Lateral Sclerosis (ALS) to retard the rate of disability.

Q2: What is its administration?
A2: EDARAKAL is administered intravenously as an infusion by a medical professional, typically in 30-60 minutes.

Q3: Does it treat ALS?
A3: No, it does not cure ALS but delays the rate of functional decline, allowing patients to remain independent longer.

Q4: Is it long-term safe?
A4: Long term usage is deemed to be safe with medical supervision, but liver functions and allergic reactions have to be monitored periodically.

Indications

  • Acute ischemic stroke- to minimize neurological disability Amyotrophic Lateral Sclerosis (ALS) - reduces the pace of the disease Neurological diseases related to oxidative stress

FAQ

Q1: What is EDARAKAL Injection?
A1: It is primarily applied in acute ischemic stroke and in patients with Amyotrophic Lateral Sclerosis (ALS) to retard the rate of disability.

Q2: What is its administration?
A2: EDARAKAL is administered intravenously as an infusion by a medical professional, typically in 30-60 minutes.

Q3: Does it treat ALS?
A3: No, it does not cure ALS but delays the rate of functional decline, allowing patients to remain independent longer.

Q4: Is it long-term safe?
A4: Long term usage is deemed to be safe with medical supervision, but liver functions and allergic reactions have to be monitored periodically.

Request a Callback